Avibactam/ceftazidimeAcquired resistance: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1868卷 / 1期

关键词：

D O I：

10.1007/s40278-021-00557-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：100 / 100

相关论文

共 50 条

[41] Avibactam/ceftazidimeEmergence of acquired resistance: case report
Reactions Weekly, 2022, 1913 (1) : 90 - 90
[42] Avibactam/ceftazidimeDevelopment of drug resistance: case report
Reactions Weekly, 2020, 1808 (1) : 66 - 66
[43] OsimertinibAcquired drug resistance: 3 case reports
Reactions Weekly, 2021, 1877 (1) : 318 - 318
[44] MogamulizumabRash and drug resistance: 3 case reports
Reactions Weekly, 2024, 2032 (1) : 265 - 265
[45] AntibacterialsAcquired drug resistance: 3 case reports
Reactions Weekly, 2020, 1808 (1) : 42 - 42
[46] CrizotinibAcquired drug resistance: 3 case reports
Reactions Weekly, 2021, 1855 (1) : 128 - 128
[47] LevodopaDyskinesia and drug resistance: 3 case reports
Reactions Weekly, 2021, 1839 (1) : 171 - 171
[48] PembrolizumabPneumonitis and acquired resistance: 3 case reports
Reactions Weekly, 2021, 1879 (1) : 309 - 309
[49] OsimertinibAcquired drug resistance: 3 case reports
Reactions Weekly, 2023, 1944 (1) : 460 - 460
[50] IdelalisibAcquired resistance to Idelalisib : 3 case reports
Reactions Weekly, 2024, 2018 (1) : 234 - 234

← 1 2 3 4 5 →